Momenta Pharmaceuticals, Inc. (MNTA)

[Double_Bagel]

http://seekingalpha.com/news/1829395-teva-files-a-citizen-petition-regarding-approvability-of-generic-versions-of-copaxone?uprof=45

Teva files a citizen petition regarding approvability of generic versions of Copaxone

In response to a request from the FDA, (TEVA) files a citizen petition (CP) on the approvability of generic versions of Copaxone (glatiramer acetate injection). The agency wanted a CP in order to facilitate public review and comment on new scientific data on gene expression. This will allow Teva to comment publicly on the views and opinions of others and will create an administrative record that the FDA may use as a basis for future decisions.

Teva's CP provides new scientific data on gene expression and evidence to support arguments that active ingredient sameness, immunogenicity and bioequivalence in generic offerings are similar but not the same as Copaxone. The company says that competitive offerings should use the same gene expression markers and biological pathways to demonstrate sameness and be evaluated in full-scale clinical trials.

Teva is doing everything it can to hold on. Looks like Citi's call that Copaxone approval won't happen until the end of the year is looking more and more reasonable.